Marinomed Biotech AG
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Marinomed Biotech AG is a science-based biopharmaceutical company that develops innovative therapies for diseases in virology and immunology. The company leverages two proprietary technology platforms: Carragelose®, a virus-blocking compound used in globally marketed nasal sprays and lozenges, and Marinosolv®, a technology platform that enhances the solubility of poorly soluble compounds to develop new treatments for various immunological conditions. Marinomed's business model encompasses in-house development of medicinal products and medical devices, as well as strategic partnerships to commercialize its pipeline and technologies. The company focuses on addressing conditions with limited or no effective treatment options, particularly in respiratory and autoreactive immune disorders.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Marinomed Biotech AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-06 15:20 |
M&A Activity
Marinomed Biotech AG announces partnership for Budesolv in Switzerland
|
English | 8.2 KB | |
| 2025-06-04 09:32 |
Major Shareholding Notification
EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 Börs…
|
English | 31.6 KB | |
| 2025-06-04 09:31 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Veröffentlichung gemäß § 135 Abs. 2 BörseG mit d…
|
German | 31.9 KB | |
| 2025-06-04 09:30 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | |
| 2025-06-04 09:29 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 Börs…
|
English | 31.6 KB | |
| 2025-06-04 09:29 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Veröffentlichung gemäß § 135 Abs. 2 BörseG mit d…
|
German | 31.9 KB | |
| 2025-05-14 10:01 |
Pre-Annual General Meeting Information
EQS-AGM: Supplemented Version of the Convocation published on May 12, 2025 for …
|
English | 50.4 KB | |
| 2025-05-14 10:01 |
Pre-Annual General Meeting Information
EQS-HV: Ergänzte Fassung der am 12. Mai 2025 veröffentlichten Einberufung der 8…
|
German | 45.1 KB | |
| 2025-05-14 10:00 |
Pre-Annual General Meeting Information
Supplemented Version of the Convocation published on May 12, 2025 for the 8th A…
|
English | 22.0 KB | |
| 2025-05-12 11:25 |
Pre-Annual General Meeting Information
Marinomed Biotech AG: Invitation to the 8th Annual General Meeting on Wednesday…
|
English | 21.7 KB | |
| 2025-05-08 09:20 |
Earnings Release
Marinomed Biotech AG announces results for the first quarter of 2025
|
English | 12.1 KB | |
| 2025-04-16 07:48 |
Annual Report
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
|
English | 5.5 MB | |
| 2025-04-16 07:48 |
Annual Report
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 2.1 MB | |
| 2025-04-16 07:47 |
Management Discussion and Analysis
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 5.5 MB | |
| 2025-04-16 07:45 |
Report Publication Announcement
|
English | 3.1 KB |
Automate Your Workflow. Get a real-time feed of all Marinomed Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Marinomed Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
